# Sulforaphane Pre-Treatment Improves Alveolar Macrophage Killing After Alcohol-Induced Phagocytic Dysfunction In Vitro and in Galleria mellonella Larvae

**Authors:** Caleb Harrop, Nathan Clark, Robert Darby, Dallen James, Scott Quimby, Braydon Black, Vincent Tran, Ethan Ostrom, Tinna Traustadóttir, Fernando P. Monroy, Victor M. Jimenez

PMC · DOI: 10.3390/medicines13010008 · Medicines · 2026-02-19

## TL;DR

Sulforaphane pretreatment helps macrophages fight infections better after alcohol exposure, both in cells and in insect models.

## Contribution

This study shows sulforaphane can prevent alcohol-induced immune dysfunction and improve pathogen killing in macrophages.

## Key findings

- SFN pretreatment improved macrophage pathogen killing by 12- to 20-fold after alcohol exposure.
- SFN reduced TNF-α levels and improved survival in Galleria mellonella larvae infected with pathogens.
- SFN protection was effective against both Gram-positive and Gram-negative bacteria.

## Abstract

Background: Alcohol is associated with increased mortality and morbidity globally. Pulmonary infections with opportunistic pathogens can occur in healthy humans; however, binge alcohol intoxication (≥0.08% BAC) is a major risk factor. We have previously shown that a single dose of alcohol comparable to binge alcohol intoxication increases infection by reducing alveolar macrophage function in vivo. Sulforaphane (SFN), a phytonutrient, is a potent inducer of antioxidant production through the induction of nuclear factor erythroid 2-related factor 2 (Nrf2) and inhibition of the nuclear factor kappa-light-chain-enhancer (NF-kB) pathway. The aim of this study was to test the therapeutic potential of SFN given as a pretreatment to prevent alcohol-induced phagocytic dysfunction. Methods: Intracellular phagocytic killing was measured via colony-forming units (CFU) and cytokine expression via ELISA. G. mellonella survival was used to determine the therapeutic potential of SFN in vivo. Results: Dose–response curves indicated that SFN concentrations of less than 20 µM were not cytotoxic in either MH-S (murine) or THP-1 (human) cells. Live infection assay results showed that MH-S and THP-1 cells pretreated with SFN (5 µM) and challenged with 0.2% (v/v) alcohol for 3 or 8 h prior to live B. thailandensis or S. epidermidis infection improved intracellular pathogen killing between 12- and 20-fold compared to macrophages treated with alcohol alone. ELISA analysis indicated that SFN significantly reduced levels of Tumor necrosis factor-alpha (TNF-α) expression at 3 and 8 h compared to controls. Additionally, a Galleria mellonella larvae model demonstrated greater survivability in the prophylaxis group compared to larvae exposed to either Gram-positive or Gram-negative pathogens, as well as in groups that received alcohol prior to pathogen inoculation. Conclusions: Taken together, SFN-induced cytoprotection was extended beyond in vitro cell culture to include an in vivo G. mellonella model demonstrating protection against Gram-positive and negative opportunistic pathogens. These data demonstrate that SFN may be an effective pretreatment option to prevent alcohol-mediated innate immune dysfunction and restore macrophage phagocytic killing.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Proteins:** TNF (tumor necrosis factor)
- **Chemicals:** sulforaphane (PubChem CID 5350), alcohol (PubChem CID 702)
- **Species:** Mus musculus (taxon 10090), Galleria mellonella (taxon 7137)

## Full-text entities

- **Genes:** CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, MIF (macrophage migration inhibitory factor) [NCBI Gene 4282] {aka GIF, GLIF, MMIF}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, REXO2 (RNA exonuclease 2) [NCBI Gene 25996] {aka CGI-114, REX2, RFN, SFN}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IRAK1 (interleukin 1 receptor associated kinase 1) [NCBI Gene 3654] {aka IRAK, pelle}, KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817] {aka INrf2, KLHL19}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, DEFB4A (defensin beta 4A) [NCBI Gene 1673] {aka BD-2, DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2}
- **Diseases:** macrophage dysfunction (MESH:D055501), viral infections (MESH:D014777), opportunistic bacterial infections (MESH:D009894), nosocomial infections (MESH:D003428), Phagocytic Dysfunction (MESH:D010585), pulmonary inflammatory (MESH:D016726), COVID-19 (MESH:D000086382), inflammation (MESH:D007249), binge (MESH:D002032), injury to (MESH:D014947), Pulmonary infections (MESH:D012141), Infection (MESH:D007239), BAI (MESH:D000435), prostate cancer (MESH:D011471), fungal infections (MESH:D009181), bacterial (MESH:D001424), death (MESH:D003643), pneumonia (MESH:D011014), cytotoxic (MESH:D064420), immune dysfunction (MESH:D007154), diseases of the respiratory system (MESH:D015619), alcohol abuse (MESH:D000437), diabetic (MESH:D003920), liver, brain, and gastrointestinal tract disorders (MESH:D005767)
- **Chemicals:** SFN (MESH:C016766), penicillin (MESH:D010406), DMSO (MESH:D004121), amino acids (MESH:D000596), Cys (MESH:D003545), kanamycin (MESH:D007612), metal (MESH:D008670), LPS (MESH:D008070), sodium bicarbonate (MESH:D017693), DPBS (MESH:C012939), isothiocyanate (MESH:C037152), CO2 (MESH:D002245), carbohydrates (MESH:D002241), glucose (MESH:D005947), streptomycin (MESH:D013307), glucoraphanin (MESH:C119494), APCmin (-), polystyrene (MESH:D011137), ethanol (MESH:D000431), Triton X-100 (MESH:D017830), L-glutamine (MESH:D005973), ALC (MESH:D000438), phenol red (MESH:D010637), PMA (MESH:D013755), HEPES (MESH:D006531), agar (MESH:D000362), lipid (MESH:D008055)
- **Species:** Chlamydia (genus) [taxon 810], Vibrio (genus) [taxon 662], Rattus norvegicus (brown rat, species) [taxon 10116], Burkholderia thailandensis (species) [taxon 57975], Chlamydia trachomatis (species) [taxon 813], Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573], Galleria mellonella (greater wax moth, species) [taxon 7137], Streptococcus pneumoniae (species) [taxon 1313], Mus musculus (house mouse, species) [taxon 10090], Staphylococcus aureus (species) [taxon 1280], Rodentia (rodent, order) [taxon 9989], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Vespa orientalis (oriental hornet, species) [taxon 7447], Homo sapiens (human, species) [taxon 9606], Hexapoda (hexapods, subphylum) [taxon 6960], Burkholderia pseudomallei (species) [taxon 28450], Staphylococcus epidermidis (species) [taxon 1282], Shigella (genus) [taxon 620], Mycobacterium avium complex sp. (species) [taxon 37162]
- **Cell lines:** PC-3 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0035), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), N9 — Mus musculus (Mouse), Transformed cell line (CVCL_0452), DU145 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_0105), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), AM — Helicoverpa zea (Corn earworm moth), Spontaneously immortalized cell line (CVCL_Z401), MH-S — Mus musculus (Mouse), Transformed cell line (CVCL_3855), Neuro2a — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028045/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028045/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028045/full.md

---
Source: https://tomesphere.com/paper/PMC13028045